Few & Far Between: Conversations from the Front Lines of Drug Development

Episode 47 - Marc Lajoie, CEO at Outpace Bio

Dec 31, 2024

48:25

forum

Ask episode

view_agenda

Chapters

auto_awesome

Transcript

info_circle

Episode notes

"If you bring powerful technology to a problem that is well understood, then you can really make a difference." - Marc Lajoie, CEO at Outpace Bio

Welcome to the latest episode of Biorasi's Few & Far Between podcast. Join host Chris O'Brien and guest, Marc Lajoie, as they discuss how de novo proteins can be used to reprogram immune cells.

Tune in today!

Home Top podcasts Popular guests